Michael E. Kupferman

The University of Texas MD Anderson Cancer Center

Papers

12

Total Citations

983

H-Index

10

About

Michael E. Kupferman is a pioneering surgeon and researcher whose work has fundamentally shaped the field of robotic and minimally invasive surgery for head and neck cancers. His research focuses primarily on transoral robotic surgery (TORS), skull base surgery, and functional and oncologic outcomes in oropharyngeal cancer management. Kupferman has been instrumental in establishing the clinical validity of TORS, contributing to landmark multi-institutional studies that have collectively garnered hundreds of citations — including a 2015 outcomes analysis with over 300 citations and a 2014 systematic review of functional outcomes with 232 citations. Notably, his early work on robotic endoscopic skull base surgery (2007, 146 citations) helped define an entirely new surgical frontier, demonstrating tremor-free, two-handed dissection in previously inaccessible anatomical regions. His involvement in the pivotal ECOG-ACRIN E3311 trial reflects his commitment to refining radiation dose de-escalation strategies following robotic surgery. Across his portfolio, Kupferman consistently addresses patient quality of life, including swallowing function, gastrostomy tube dependency, and weight loss — underscoring a career dedicated to advancing surgical precision while minimizing treatment-related morbidity.

Research Focus

Key Achievements

10
H-Index
12
Papers
983
Total Citations
82
Avg Citations/Paper
🏆 Most Cited Paper
Oncologic Outcomes After Transoral Robotic Surgery
304 citations · 2015
📈 Most Prolific Year: 2017 (3 Papers)
🤝 Key Collaborators: 61
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago